2015
Suven Life Sciences bags Pharmexcil's "Gold Patent Award"
SUVN502 - Completed phase 1b clinical trial under US-IND.
SUVNG3031 - Completed SAD and MAD studies of phase 1 clinical trial under USIND
SUVN-D4010 – IND filed in USA
Suven facility at JNPC, Vishakapatnam, Andhra Pradesh has commenced commercial operations
SUVN-D4010 for Cognition in Alzheimer’s disease commenced Phase 1 Clinical Trial in USA under US-IND126099
Suven has created a wholly owned subsidiary, Suven, Inc., a Delaware Company in USA
Suven initiates Phase 2A trial of SUVN-502 in USA